Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03993912
Title Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy (IFM2017_03)
Acronym IFM2017_03
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University Hospital, Lille
Indications
Therapies
Age Groups: senior
Covered Countries FRA

Facility Status City State Zip Country Details
Chru Jean Minjoz Besançon France Details
Ch Blois Simone Veil Blois France Details
Ch Fleyriat Bourg-en-Bresse France Details
Chru Brest Site Hopital Morvan Brest France Details
Chu de Caen Normandie Caen France Details
Hopital Prive Sevigne - Cesson Cesson-Sévigné France Details
Chu Dijon Bourgogne Dijon France Details
Chu de Grenoble Grenoble France Details
Gpe Hospitalier La Rochelle-Re-Aunis La Rochelle France Details
Ch Chartres Louis Pasteur-Le Coudray Le Coudray France Details
Hôpital Claude Huriez, CHU Lille France Details
Institut Paoli Calmettes Marseille France Details
Chi Mont de Marsan Et Pays Des Sources Mont-de-Marsan France Details
Chu Montpellier Montpellier France Details
Chu de Nantes Site Hotel Dieu Hme Nantes France Details
Chu de Nice Hopital de L'Archet Nice France Details
Hopital Haut-Leveque - Chu Pessac 33604 France Details
Centre Hospitalier de Perigueux Périgueux France Details
Chru Rennes Site Pontchaillou Rennes France Details
Centre Hospitalier Saint-Malo Saint-Malo France Details
Centre Hospitalier de Saint Quentin Saint-Quentin France Details
Oncopole Chu Toulouse Toulouse France Details
Chu de Tours Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field